Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK

Michael P Mohning1,2, Stacey M Thomas1, Lea Barthel1

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.

Insights

Microparticles accumulate during acute lung injury. Resident alveolar macrophages clear these inflammatory mediators via MerTK-mediated phagocytosis, aiding in lung injury resolution.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cell Biology

Background:

  • Microparticles are emerging mediators in lung inflammation and injury.
  • Mechanisms regulating microparticle accumulation and clearance are poorly understood.

Purpose of the Study:

  • To investigate if alveolar macrophages engulf microparticles.
  • To elucidate the mechanisms of microparticle uptake by macrophages.

Main Methods:

  • Quantification of alveolar microparticles in LPS/HCl-induced lung injury models.
  • In vitro and in vivo assessment of fluorescently labeled microparticle uptake by macrophages.
  • Analysis of endocytosis inhibitors and phosphatidylserine receptor expression (MerTK, Axl).

Main Results:

  • Microparticle numbers peaked during peak inflammation and decreased with resolution.
  • Macrophage-mediated phagocytosis, inhibited by cytochalasin D and wortmannin, was confirmed.
  • Resident alveolar macrophages, expressing high levels of MerTK and Axl, were primary engulfers.
  • MerTK deficiency significantly reduced microparticle uptake both in vitro and in vivo.

Conclusions:

  • Microparticles are released during acute lung injury, with numbers correlating to inflammation severity.
  • Resident alveolar macrophages are key in clearing microparticles through MerTK-dependent phagocytosis.
  • Efficient microparticle clearance by macrophages is crucial for resolving lung injury.